China Resources Sanjiu Medical & Pharmaceutical Co Ltd Strategic Asset Allocation Index
China Resources Sanjiu Medical & Pharmaceutical Co Ltd strategic asset allocation index. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Strategic Asset Allocation Index of 27.7% as of September 2023. Strategic assets (PP&E of CN¥6.56 Billion plus long-term investments of CN¥-) total CN¥6.56 Billion, measured against net assets of CN¥23.63 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check China Resources Sanjiu Medical & Pharmac (000999) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (2000–2021)
Strategic asset allocation index of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 2000 to 2021. This chart shows how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of September 2023, the index stands at 27.7%, representing strategic assets of CN¥6.56 Billion against net assets of CN¥23.63 Billion CNY.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2000–2021)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 000999 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 26.8% | CN¥4.23 Billion | CN¥4.23 Billion | CN¥- | CN¥15.77 Billion | ▲ +0.0 pp |
| 2020 | 26.8% | CN¥3.77 Billion | CN¥3.77 Billion | CN¥- | CN¥14.05 Billion | ▼ -1.1 pp |
| 2019 | 27.9% | CN¥3.65 Billion | CN¥3.61 Billion | CN¥41.82 Million | CN¥13.08 Billion | ▼ -4.1 pp |
| 2018 | 32.0% | CN¥3.57 Billion | CN¥3.53 Billion | CN¥47.54 Million | CN¥11.17 Billion | ▼ -3.2 pp |
| 2017 | 35.2% | CN¥3.57 Billion | CN¥3.56 Billion | CN¥13.46 Million | CN¥10.13 Billion | ▼ -2.4 pp |
| 2016 | 37.7% | CN¥3.29 Billion | CN¥3.27 Billion | CN¥13.89 Million | CN¥8.72 Billion | ▼ -2.7 pp |
| 2015 | 40.4% | CN¥3.10 Billion | CN¥3.08 Billion | CN¥22.68 Million | CN¥7.67 Billion | ▲ +0.2 pp |
| 2014 | 40.2% | CN¥2.81 Billion | CN¥2.81 Billion | CN¥- | CN¥7.00 Billion | ▼ -9.8 pp |
| 2013 | 49.9% | CN¥3.09 Billion | CN¥3.09 Billion | CN¥- | CN¥6.20 Billion | ▲ +1.9 pp |
| 2012 | 48.1% | CN¥2.70 Billion | CN¥2.70 Billion | CN¥- | CN¥5.61 Billion | ▲ +2.8 pp |
| 2011 | 45.3% | CN¥2.20 Billion | CN¥2.20 Billion | CN¥- | CN¥4.85 Billion | ▲ +15.0 pp |
| 2010 | 30.2% | CN¥1.43 Billion | CN¥1.43 Billion | CN¥- | CN¥4.73 Billion | ▼ -6.1 pp |
| 2009 | 36.3% | CN¥1.44 Billion | CN¥1.44 Billion | CN¥- | CN¥3.95 Billion | ▼ -2.6 pp |
| 2008 | 39.0% | CN¥1.33 Billion | CN¥1.33 Billion | CN¥- | CN¥3.41 Billion | ▲ +0.4 pp |
| 2007 | 38.6% | CN¥1.14 Billion | CN¥1.14 Billion | CN¥- | CN¥2.96 Billion | ▼ -1.2 pp |
| 2006 | 39.8% | CN¥1.04 Billion | CN¥1.04 Billion | CN¥- | CN¥2.61 Billion | ▼ -4.2 pp |
| 2005 | 44.0% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥2.39 Billion | ▼ -2.8 pp |
| 2004 | 46.8% | CN¥1.07 Billion | CN¥1.07 Billion | CN¥- | CN¥2.29 Billion | ▲ +13.1 pp |
| 2003 | 33.7% | CN¥1.03 Billion | CN¥1.03 Billion | CN¥- | CN¥3.05 Billion | ▲ +3.0 pp |
| 2002 | 30.7% | CN¥913.45 Million | CN¥913.45 Million | CN¥- | CN¥2.97 Billion | ▲ +4.4 pp |
| 2001 | 26.3% | CN¥776.21 Million | CN¥776.21 Million | CN¥- | CN¥2.95 Billion | ▼ -1.6 pp |
| 2000 | 27.9% | CN¥799.33 Million | CN¥799.33 Million | CN¥- | CN¥2.87 Billion | — |